| __timestamp | Pfizer Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8393000000 | 293000 |
| Thursday, January 1, 2015 | 7690000000 | 1002000 |
| Friday, January 1, 2016 | 7872000000 | 888000 |
| Sunday, January 1, 2017 | 7657000000 | 19623000 |
| Monday, January 1, 2018 | 8006000000 | 30421000 |
| Tuesday, January 1, 2019 | 8650000000 | 34794000 |
| Wednesday, January 1, 2020 | 9405000000 | 28304000 |
| Friday, January 1, 2021 | 13829000000 | 56886000 |
| Saturday, January 1, 2022 | 11428000000 | 100894000 |
| Sunday, January 1, 2023 | 10679000000 | 159765000 |
| Monday, January 1, 2024 | 10930000000 |
Cracking the code
In the ever-evolving world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Pfizer Inc. has consistently demonstrated its dedication to advancing medical science, with R&D expenses peaking at approximately $13.8 billion in 2021. This represents a significant increase of nearly 80% from 2014. In contrast, Viridian Therapeutics, Inc., a smaller player in the industry, has shown a remarkable growth trajectory in its R&D investments, starting from a modest $293,000 in 2014 to nearly $160 million by 2023. This exponential increase underscores Viridian's strategic focus on innovation, despite its smaller scale. The data highlights the contrasting strategies of a pharmaceutical giant and an emerging innovator, each playing a crucial role in shaping the future of healthcare.
Eli Lilly and Company vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
AbbVie Inc. vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Novartis AG vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Pfizer Inc. and Insmed Incorporated
Research and Development: Comparing Key Metrics for Pfizer Inc. and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Travere Therapeutics, Inc.
R&D Spending Showdown: Neurocrine Biosciences, Inc. vs Viridian Therapeutics, Inc.
Bio-Techne Corporation or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and Viridian Therapeutics, Inc.
Research and Development Investment: Amicus Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Comparing Innovation Spending: Geron Corporation and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.